Position in INVA
as of Mar 31, 2026
· filed Jun 18, 2026
Position Value
$8,380,031
+$756,385 QoQ
Shares Held
359,658
-5.7% QoQ
Ownership
0.487%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in INVA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Pacer Advisors, Inc. holds $745,075,920 across 25 Biotechnology names. INVA ranks #10 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
358,633 | $277,094,201 | |
| 2 | INCY |
Incyte Corp
|
1,741,061 | $163,868,661 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
503,013 | $95,094,607 | |
| 4 | EXEL |
Exelixis, Inc.
|
1,549,611 | $66,462,815 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
88,863 | $39,680,884 | |
| 6 | RPRX |
Royalty Pharma plc
|
689,194 | $33,060,636 | |
| 7 | HALO |
Halozyme Therapeutics, Inc.
|
295,524 | $19,099,716 | |
| 8 | CPRX |
Catalyst Pharmaceuticals, Inc.
|
361,794 | $8,958,019 |
All Filings in INVA
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $8,380,031 | 359,658 | Shares | Sole | 2026-06-18 | |
| 2025-12-31 | $7,623,646 | 381,373 | Shares | Sole | 2026-02-24 | |
| 2025-09-30 | $8,479,351 | 464,622 | Shares | Sole | 2025-10-15 | |
| 2025-06-30 | $10,316,435 | 513,511 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $12,972,377 | 715,520 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $50,872,160 | 2,932,113 | Shares | Sole | 2025-01-22 | |
| 2024-09-30 | $54,279,463 | 2,810,951 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $55,080,400 | 3,358,561 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $51,219,689 | 3,360,872 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $27,732,903 | 1,728,984 | Shares | Sole | 2024-01-16 | |
| 2023-09-30 | $18,835 | 1,450 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $11,959,478 | 939,472 | Shares | Sole | 2023-07-12 | |
| 2023-03-31 | $18,412,807 | 1,636,694 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $20,387,165 | 1,538,654 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $17,129,370 | 1,475,398 | Shares | Sole | 2022-10-18 | |
| 2022-06-30 | $16,300,412 | 1,104,364 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $13,957,232 | 721,304 | Shares | Sole | 2022-04-05 | |
| 2021-12-31 | $11,208,101 | 649,745 | Shares | Sole | 2022-02-03 | |
| 2021-09-30 | $7,247,110 | 433,699 | Shares | Sole | 2021-10-15 | |
| 2021-06-30 | $6,350,640 | 473,575 | Shares | Sole | 2021-07-21 | |
| 2021-03-31 | $3,420,173 | 286,207 | Shares | Sole | 2021-04-05 | |
| 2020-12-31 | $981,957 | 79,254 | Shares | Sole | 2021-01-20 | |
| 2020-09-30 | $469,581 | 44,936 | Shares | Sole | 2020-10-19 | |
| 2020-06-30 | $432,513 | 30,938 | Shares | Sole | 2020-07-29 | |
| 2020-03-31 | $284,497 | 24,192 | Shares | Sole | 2020-04-23 | |
| No filing history on record for this holder in this stock. | ||||||